CytoDyn Explains How Documentary Movies Are Made.

LOS ANGELES -- As previously reported on May 11, 2009, Evolution Media of Burbank, CA is producing a video documentary about Cytolin[R], the first immune modulator for treating HIV/AIDS that has consistently shown serological and clinical benefits in early human experience. It is the lead drug of CytoDyn, Inc. (Pink Sheets:CYDY).

Recently, CytoDyn has been receiving calls from its shareholders asking why the documentary is not yet available for viewing over the Internet. Many people who do not work in the entertainment industry probably believe that the task of producing a video documentary is only slightly more cumbersome than the making of a home movie using a modern digital camera and the widely available editing software/freeware. As a consequence, the Company has a desire and, arguably, a duty to explain how documentary movies are made for the benefit of its shareholders.

PRE-PRODUCTION

CASTING: The first step was to determine a cast of experts who could talk about the subjects that the documentary covers: epidemiology, science, medicine, drug development, and bio-economics. In addition to being knowledgeable, cast members had to be articulate and, since this is television, needed to present a decent and professional image to the camera. They also needed to be willing. Unlike entertainment projects that pay actors anywhere from union scale to millions of dollars for their performances, individuals appearing in a documentary are usually not compensated. Not surprisingly, therefore, most but not all of the cast members are CytoDyn employees.

SCRIPT: Once the cast was determined, a list of questions was prepared for each member of the cast. Although the questions themselves do not appear in the documentary, the director asked each member of the cast a series of questions in order to have him or her expound on the desired subjects. The same question was asked repeatedly in order to get different "takes" from the individual being interviewed.

LOCATIONS: The physical locations where the documentary was shot were determined on the basis of logistics, cost, and visual appeal. The documentary was shot in two locations, one in Southern California and one in Arizona.

PRINCIPAL PRODUCTION

Once the cast, script and locations had been determined, the next step was to tape the raw footage from which the documentary was assembled. The raw footage was shot over a period of two days, one day in each location. A minimum crew was used that included a director, a camera operator, a gaffer to handle lighting, a sound engineer to record the dialog, a boom operator to hold the microphone boom, and a make-up artist. About six hours of raw footage was shot for what ended up being the short documentary intended.

POST-PRODUCTION

PAPER CUT: A written transcript was prepared indicating exactly what each cast member said during the six hours of raw footage. This transcript was used to select the footage that was used for the documentary so that each desired subject was covered in as clear and compelling a way as possible.

GRAPHIC ELEMENTS: Graphic cards were prepared that indicate the beginning of each section of the documentary, which is divided into five sections:

* The global impact of the HIV pandemic.

* The limitations of the generally successful antiretroviral drugs used to treat HIV/AIDS, and the increasing need for immune-based drugs.

* The multicenter scientific research that led to Cytolin[R], an immune-based drug, and the clinical and serologic benefits that have been seen in patients treated with Cytolin[R].

* Stage of drug development.

* An invitation to viewers to learn more over the Internet.

MUSIC: CytoDyn's CEO, Allen D. Allen, in addition to being a scientist with an extensive bibliography of papers published in the peer-review science and medical journals, is a Life Member of the American Federation of Musicians, a composer/lyricist member of ASCAP, and a recipient of the 1958 BMI Country Music Award. He spent many previous years as a successful film composer. Consequently, CytoDyn provided the music for the documentary.

PRELIMINARY ROUGH CUT: The selected videotaped segments were assembled, the graphic cards added, and the music dubbed into the sound track to produce a Preliminary Rough Cut. The Preliminary Rough Cut was presented to the staff at Evolution, and to CytoDyn, which is concerned with the accuracy of material related to science and medicine, as well as public relations, and regulatory compliance. It was determined that there needed to be three minor revisions to the Preliminary Rough Cut in order to have a Final Rough Cut, which is being created as of this writing.

B-ROLL FOOTAGE: B-Roll Footage refers to live action that illustrates what an individual being interviewed is talking about. This will be added to the Final Rough Cut to produce a Final Cut or "Negative" so that the documentary will consist of more than just "talking heads." Because the documentary covers several subjects, some of which are technical and others of which concern the human experience, the B-Roll Footage shot during Principal Production will not be adequate and must be supplemented by stock footage. This is typical of documentaries that are concerned with more than just a few products, all of which could be filmed or taped in one location, such as a factory.

STOCK FOOTAGE: Because HIV/AIDS is a real and a serious disease, CytoDyn has presented Evolution with the daunting challenge of securing stock footage that is precise and accurate. In entertainment projects, stock footage is often imprecise and inaccurate. In the film "Deterrence," for example, a movie that was produced after the Gulf War and ironically shown on television one day before 9/11/2001, a 100 megaton hydrogen bomb explodes over Baghdad in an imaginary future. The stock footage used for the nuclear explosion shows the test of an atomic bomb that was conducted at sea by the U.S. in the South Pacific prior to the Test Ban Treaty. You can just see the ring of ships anchored around the detonation site. For the attentive viewer, this pretty much destroys suspension of disbelief and the idea that the bomb detonated over Iraq. Having this kind of inaccuracy in the documentary would, in CytoDyn's opinion, be socially irresponsible and could invite complaints from regulators.

LOOKING FORWARD

CytoDyn hopes that the documentary will be completed within a few weeks but there is no guarantee that this will be the case. More generally, this press release contains forward-looking statements that are not historical facts. CytoDyn's management makes forward-looking statements concerning the Company's expected future operations, performance and other developments. These forward-looking statements are necessarily estimates based upon current information and projections and involve a number of risks and uncertainties, including but not limited to, the failure of preliminary results from clinical studies to reflect the results from more comprehensive studies. There can be no assurance that such risks and uncertainties, or other factors, will not affect the accuracy of such forward-looking statements. It is impossible to identify all the factors that could cause actual results to differ materially from those estimated by CytoDyn. They include, but are not limited to, government regulation, managing and maintaining growth, victimization by white-collar offenders, and the effects of adverse publicity, litigation, competition, and other factors that may be identified from time to time in the Company's announcements.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5986194&lang=en.